Hippocampal Temporal Interference Stimulation for Memory and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

November 8, 2026 updated by: Jiaojiao Lü, PhD, Shanghai University of Sport

Effects and Underlying Mechanisms of Hippocampal-Targeted Temporal Interference Stimulation on Memory Function and Dual-Task Postural Control in Older Adults With Mild Cognitive Impairment

This randomized crossover study aims to investigate the immediate effects of hippocampal temporal interference stimulation (TIS) on memory and dual-task postural control in older adults with mild cognitive impairment (MCI).

Participants are assigned to receive three stimulation conditions: 40 Hz TIS, 5 Hz TIS, and sham stimulation. Each condition is administered in a separate session in a randomized order, with at least 7 days between consecutive sessions.

The study compares memory and dual-task postural control across the three stimulation conditions. Memory and dual-task postural control assessments are planned before and after each stimulation session.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

21

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jiaojiao Lü, PhD
  • Phone Number: +86 18516565889
  • Email: ljj27@163.com

Study Locations

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200438
        • Recruiting
        • Shanghai University of Sport
        • Contact:
          • Ethics Committee of the Shanghai University of Sport
          • Phone Number: +86 21 65508179
          • Email: lunli@sus.edu.cn

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

  1. Age 65 years or older.
  2. Presence of subjective memory complaints.
  3. Objective cognitive impairment, defined as a corrected MoCA-BJ total score of less than 26. The MoCA-BJ has a maximum score of 30. For participants with no more than 12 years of education, 1 point is added to the raw score, and the corrected total score is capped at 30 points.
  4. Global Clinical Dementia Rating (CDR) score of 0.5.
  5. No diagnosis of dementia, with an MMSE score of at least 18 for illiterate participants, at least 21 for those with primary school education, and at least 25 for those with junior high school education or above.
  6. Remains independent in activities of daily living (ADL) and is able to cooperate with all assessments and interventions.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 40 Hz Temporal Interference Stimulation

Participants receive one 20-minute session of active 40 Hz temporal interference stimulation (TIS) targeting the left hippocampus. In this randomized crossover study, participants are also assigned to receive 5 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 40 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Other Names:
  • TIs
Sham Comparator: sham group

Participants receive one 20-minute session of sham temporal interference stimulation (TIS), using the same electrode placement and setup as the 40 Hz TIS session. In this randomized crossover study, participants are also assigned to receive 40 Hz and 5 Hz TIS in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the sham stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Other Names:
  • TIs
Experimental: 5 Hz Temporal Interference Stimulation

Participants receive one session of active 5 Hz temporal interference stimulation (TIS). In this randomized crossover study, participants are also assigned to receive 40 Hz TIS and sham stimulation in separate sessions, with at least 7 days between consecutive stimulation sessions. Memory and dual-task postural control are assessed before and after the 5 Hz stimulation session.

Transcranial temporal interference stimulation (TIS) is a noninvasive brain stimulation technique. In this randomized crossover study, participants are assigned to receive 40 Hz TIS, 5 Hz TIS, and sham stimulation in separate sessions in a randomized order, with at least 7 days between consecutive stimulation sessions. The 40 Hz TIS session targets the left hippocampus and lasts 20 minutes. The sham session uses the same electrode placement and setup as the 40 Hz TIS session and lasts 20 minutes. Memory and dual-task postural control assessments are planned before and after each of the three stimulation sessions.

Other Names:
  • TIs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Accuracy After Stimulation
Time Frame: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized object-scene associative memory task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct match/non-match responses divided by the total number of valid retrieval trials and multiplied by 100. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Object-Scene Associative Memory Retrieval Reaction Time After Stimulation
Time Frame: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the object-scene associative memory task. Mean reaction time is calculated using valid trials with correct responses. Trials with no response or reaction times shorter than 300 milliseconds are excluded. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change From Pre-intervention in Word Recognition Accuracy After Stimulation
Time Frame: Immediately before and after each 20-minute stimulation session during each crossover period

Accuracy is assessed using a computerized word-recognition task programmed in E-Prime 3.0. Accuracy is calculated as the number of correct responses divided by the total number of analyzed trials and multiplied by 100. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Higher accuracy indicates better performance.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Word Recognition Reaction Time After Stimulation
Time Frame: Immediately before and after each 20-minute stimulation session during each crossover period

Reaction time is recorded by E-Prime 3.0 during the word-recognition task. Mean reaction time is calculated using valid trials with correct responses. The two recognition cycles are analyzed separately. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. Shorter reaction times indicate faster responses.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 3-Meter Timed Up and Go Completion Time After Stimulation
Time Frame: Immediately before and after each 20-minute stimulation session during each crossover period

Participants perform the 3-meter Timed Up and Go test under single-task and dual-task conditions. During the dual-task condition, participants complete the test while continuously subtracting 3 from a randomly selected three-digit number. Total completion time is measured in seconds using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean completion time is used. Dual-task cost is calculated as: [(dual-task completion time - single-task completion time) / single-task completion time] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates greater deterioration in mobility performance under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Change From Pre-intervention in Dual-Task Cost of 7-Meter Walking Speed After Stimulation
Time Frame: Immediately before and after each 20-minute stimulation session during each crossover period

Participants complete the 7-meter walking test at their usual comfortable speed under single-task and dual-task conditions. During the dual-task condition, participants walk while continuously subtracting 3 from a randomly selected three-digit number. Walking speed is measured in meters per second using the Mobility Lab wearable motion analysis system. Each condition is tested three times, and the mean walking speed is used. Dual-task cost is calculated as: [(single-task walking speed - dual-task walking speed) / single-task walking speed] × 100%. The reported outcome is the post-intervention value minus the pre-intervention value within each stimulation period. A higher dual-task cost indicates a greater reduction in walking speed under cognitive load.

Immediately before and after each 20-minute stimulation session during each crossover period
Number of Participants With Any Stimulation-Associated Adverse Symptom
Time Frame: During and immediately after each 20-minute stimulation session in each crossover period

Safety is assessed using a standardized adverse-reaction questionnaire completed immediately after each stimulation session. Prespecified symptoms include tingling, itching, burning sensation, pain, skin redness, fatigue, visual sensations, difficulty concentrating, and mood changes. Each symptom is rated as none, mild, moderate, or severe, corresponding to scores of 0, 1, 2, and 3, respectively. Other spontaneously reported symptoms are also recorded. For each stimulation condition, a participant is counted as having an adverse symptom if at least one prespecified or spontaneously reported symptom is present with a severity score of 1 or higher during or immediately after stimulation.

During and immediately after each 20-minute stimulation session in each crossover period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2026

Primary Completion (Estimated)

July 15, 2027

Study Completion (Estimated)

July 30, 2027

Study Registration Dates

First Submitted

August 8, 2026

First Submitted That Met QC Criteria

August 13, 2026

First Posted (Actual)

August 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 12, 2026

Last Update Submitted That Met QC Criteria

November 8, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ID: 102772026RT090

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.